Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 14.77% vs 23.85% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -92.08% vs -87.54% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -8.86% vs -13.52% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 13.70% vs -89.11% in Mar 2024
Compare Profit and Loss Results of Vaishali Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
99.00
173.00
-74.00
-42.77%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
99.00
173.00
-74.00
-42.77%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
0.00
-4.00
0%
Raw Materials Consumed
90.00
95.00
-5.00
-5.26%
Power & Fuel Cost
0.00
9.00
-9.00
-100.00%
Employee Cost
2.00
15.00
-13.00
-86.67%
Operating Expenses
0.00
4.00
-4.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
22.00
-20.00
-90.91%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
2.00
4.00
200.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
98.00
157.00
-59.00
-37.58%
Operating Profit (PBDIT) excl Other Income
0.00
16.00
-16.00
-100.00%
Other Income
3.00
2.00
1.00
50.00%
Operating Profit (PBDIT)
3.00
18.00
-15.00
-83.33%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
1.00
17.00
-16.00
-94.12%
Depreciation
0.00
6.00
-6.00
-100.00%
Profit Before Taxation & Exceptional Items
1.00
11.00
-10.00
-90.91%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1.00
11.00
-10.00
-90.91%
Provision for Tax
0.00
3.00
-3.00
-100.00%
Profit After Tax
0.00
8.00
-8.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
15.00
34.00
-19.00
-55.88%
Profit Available for appropriations
15.00
42.00
-27.00
-64.29%
Appropriations
15.00
42.00
-27.00
-64.29%
Equity Dividend (%)
0%
15%
-15.00
Earnings Per Share
0.06
5.82
-5.76
-98.97%
Profit And Loss - Net Sales
Net Sales 99.03 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 14.77% vs 23.85% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -92.08% vs -87.54% in Mar 2024
Profit And Loss - Interest
Interest 1.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -8.86% vs -13.52% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 0.82 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 13.70% vs -89.11% in Mar 2024






